List of articles with "Amgen"

Harbour BioMed's Legal Victory

2026-06-15 00:04:19

United States Delaware Amgen Harbour BioMed Antibody Patent

Amgen's Cardiometabolic Insights

2026-06-07 20:51:21

USA Amgen Thousand Oaks Repatha cardiometabolic

IMDYLLTRA Approval News

2026-06-03 19:43:49

Germany Amgen Thousand Oaks Lung Cancer IMDYLLTRA

IMDYLLTRA® Approved

2026-06-03 19:21:02

USA Amgen Thousand Oaks Lung Cancer IMDYLLTRA

IMDYLLTRA® Approved in Europe

2026-06-03 18:38:58

None Amgen SCLC IMDYLLTRA

IMDYLLTRA® Approved

2026-06-03 17:42:15

None Amgen SCLC IMDYLLTRA®

IMDYLLTRA® Approval

2026-06-03 15:30:02

None Amgen Lung Cancer IMDYLLTRA

Amgen's IMDYLLTRA® Approved

2026-06-03 14:52:33

None Amgen Thousand Oaks Lung Cancer IMDYLLTRA

IMDYLLTRA® Approved

2026-06-03 14:45:54

None Amgen SCLC IMDYLLTRA®

Amgen at EULAR 2026

2026-06-03 13:42:41

United States Amgen Thousand Oaks UPLIZNA EULAR

IMDYLLTRA Approval

2026-06-01 20:04:37

None Amgen small cell lung cancer IMDYLLTRA

Amgen at Jefferies 2026

2026-05-29 20:12:24

United States healthcare Amgen Thousand Oaks Conference

Amgen CFO Retirement

2026-05-19 20:12:33

None Amgen Thousand Oaks Peter Griffith Thomas Dittrich

Amgen at Healthcare Conference

2026-05-07 20:34:48

United States healthcare Amgen Thousand Oaks Conference

Amgen's $300M Boost

2026-05-04 13:56:46

United States Puerto Rico Amgen Thousand Oaks Biomanufacturing

Amgen's Q1 2026 Insights

2026-04-30 20:07:11

United States healthcare financial results Amgen Thousand Oaks

Amgen's Leadership Change

2026-04-22 20:16:34

USA biotechnology Amgen Thousand Oaks David Reese

TEPEZZA Phase 3 Results

2026-04-06 13:17:18

United States Amgen Thousand Oaks Thyroid Eye Disease TEPEZZA

Repatha® Reduces CV Risks

2026-03-28 20:48:25

USA Amgen Thousand Oaks Repatha CVS

Amgen at 2026 Global Healthcare

2026-03-05 21:12:39

United States Innovation Healthcare Conference Amgen Thousand Oaks

Amgen Dividend Update

2026-03-04 21:09:43

USA Dividend biotechnology Amgen Thousand Oaks

Amgen at TD Cowen Conference

2026-02-24 21:22:40

United States Amgen Thousand Oaks Health Care TD Cowen

Amgen's UPLIZNA® Approved

2026-02-13 21:58:23

None Amgen Myasthenia Gravis UPLIZNA

UPLIZNA® Approved

2026-02-13 19:46:57

None Amgen Myasthenia Gravis UPLIZNA

Amgen's UPLIZNA® Approved

2026-02-13 16:51:36

Amgen Thousand Oaks Czech Republic Myasthenia Gravis UPLIZNA

Amgen UPLIZNA Approval

2026-02-13 16:50:50

None Amgen Myasthenia Gravis UPLIZNA

UPLIZNA® Approved

2026-02-13 14:39:09

None Amgen Myasthenia Gravis UPLIZNA

Approval of UPLIZNA®

2026-02-12 20:44:21

None Amgen Myasthenia Gravis UPLIZNA

UPLIZNA® Approved

2026-02-12 20:18:23

None Amgen Myasthenia Gravis UPLIZNA

UPLIZNA® Approval

2026-02-12 14:40:21

United Kingdom Amgen Thousand Oaks GMG UPLIZNA®

Amgen's 2025 Growth Report

2026-02-03 21:12:01

United States financial results revenue growth Amgen Thousand Oaks

Ro and Amgen's Research

2026-01-13 13:17:05

USA New York Amgen GLP-1 Ro

Amgen Presents at Conference

2026-01-07 21:04:20

United States Healthcare Conference J.P. Morgan Amgen Thousand Oaks

Amgen Acquires Dark Blue Therapeutics

2026-01-06 16:03:12

United Kingdom Oxford Acute Myeloid Leukemia Amgen Dark Blue Therapeutics

Amgen Acquires Dark Blue

2026-01-06 15:11:00

United States oncology Amgen Thousand Oaks Dark Blue Therapeutics

Amgen's Commitment to Affordable Medicines

2025-12-19 19:25:25

United States healthcare Amgen Thousand Oaks Drug Pricing

UPLIZNA® Approved

2025-12-11 23:13:23

United States Amgen Thousand Oaks Myasthenia Gravis UPLIZNA

Amgen 2026 Dividend

2025-12-09 21:17:33

United States Dividend Amgen Thousand Oaks NASDAQ:AMGN

Amgen and LASEC Partnership

2025-12-05 14:21:26

USA Los Angeles Amgen World Cup 2026

IMDELLTRA® FDA Approval

2025-11-19 21:20:35

Amgen Thousand Oaks SCLC IMDELLTRA

Repatha® Lowers CV Event Risk

2025-11-08 15:23:27

None Amgen Repatha PCSK9 Inhibitor

Amgen Q3 2025 Results

2025-11-04 21:04:03

USA Amgen Thousand Oaks, California Repatha Otezla

Amgen's Dividend Announcement

2025-10-31 20:04:21

United States Dividend biotechnology Amgen Thousand Oaks

Repatha Phase 3 Results

2025-10-31 13:15:23

United States New Orleans Amgen Repatha Cardiovascular Trials

TEZSPIRE® Approval

2025-10-17 20:12:44

United States Amgen Thousand Oaks TEZSPIRE Allergy

AmgenNow Program

2025-10-06 13:56:06

USA Amgen Thousand Oaks Repatha AmgenNow

Repatha Trial Results

2025-10-02 14:05:13

USA Amgen Thousand Oaks Repatha VESALIUS-CV

Amgen’s $650M Expansion

2025-09-26 13:19:40

USA biopharmaceuticals Amgen Thousand Oaks USA manufacturing

Rocatinlimab Phase 3 Results

2025-09-09 00:11:50

USA Amgen Thousand Oaks Kyowa Kirin Rocatinlimab

Amgen's Major Investment

2025-09-02 13:48:03

United States Innovation Amgen Thousand Oaks Biopharmaceutical

Prev
1
2
Next

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.